Published in Int J Radiat Oncol Biol Phys on June 15, 1995
Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma. Clin Cancer Res (2011) 1.09
Imaging the facial nerve: a contemporary review. Radiol Res Pract (2013) 0.99
Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma. Br J Cancer (2004) 0.95
Radiation impairs perineural invasion by modulating the nerve microenvironment. PLoS One (2012) 0.94
Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment. Radiat Oncol (2006) 0.92
Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors. J Radiat Res (2013) 0.88
Treatment of c-kit positive adenoid cystic carcinoma of the tongue: A case report. Oncol Lett (2014) 0.88
Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study. World J Surg Oncol (2012) 0.86
Expression and function of CXCR4 in human salivary gland cancers. Clin Exp Metastasis (2012) 0.86
Clinicopathologic predictors of recurrence and overall survival in adenoid cystic carcinoma of the head and neck: a single institutional experience at a tertiary care center. Head Neck (2014) 0.86
[Malignant epithelial salivary gland tumors. Clinical review of 2 decades]. Mund Kiefer Gesichtschir (2004) 0.85
Laryngeal preservation in managing advanced tracheal adenoid cystic carcinoma. Case Rep Otolaryngol (2015) 0.85
Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study. Eur J Cancer (2015) 0.83
Adjuvant Radiotherapy with Three-Dimensional Conformal Radiotherapy of Lacrimal Gland Adenoid Cystic Carcinoma. J Clin Diagn Res (2015) 0.83
Adenoid cystic carcinoma of head and neck: clinical predictors of outcome from a Canadian centre. Curr Oncol (2016) 0.80
MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma. Laryngoscope (2015) 0.80
[Adenoid cystic carcinoma of the major and minor salivary glands. Retrospective analysis of 74 patients]. Mund Kiefer Gesichtschir (2003) 0.79
VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma. Cancer Res Treat (2015) 0.78
BH3-mimetic small molecule inhibits the growth and recurrence of adenoid cystic carcinoma. Oral Oncol (2015) 0.78
Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review. Auris Nasus Larynx (2016) 0.77
Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol (2016) 0.76
Stereotactic Radiation for Palliation of Skull Base Recurrences of Salivary Gland Carcinomas: Implications for Tumor Targeting. J Neurol Surg B Skull Base (2016) 0.75
Imaging central skull base neural tumor spread from paranasal sinus malignancies: a critical factor in treatment planning. Skull Base Surg (1999) 0.75
A case of adenoid cystic carcinoma associated with IgG4-related disease. Int J Surg Case Rep (2015) 0.75
Adenoid cystic carcinoma of head and neck: A single institutional analysis of 66 patients treated with multi-modality approach. Indian J Med Paediatr Oncol (2016) 0.75
Resection of upper lip adenoid cystic carcinoma and reconstruction with reverse Yu flap: Report of three cases and a literature review. Mol Clin Oncol (2017) 0.75
Risk factors and prognosis for salivary gland adenoid cystic carcinoma in southern china: A 25-year retrospective study. Medicine (Baltimore) (2017) 0.75
Adenoid Cystic Carcinoma in a Mexican Population. J Maxillofac Oral Surg (2015) 0.75
Expression of Autophagy and Reactive Oxygen Species-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma. Yonsei Med J (2016) 0.75
Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem. J Neurol Surg B Skull Base (2016) 0.75
Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland. J Otolaryngol Head Neck Surg (2016) 0.75
Prosthetic rehabilitation of a patient with adenoid cystic carcinoma with continuous orbital-maxillary defect. BMJ Case Rep (2013) 0.75
Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis. Strahlenther Onkol (2017) 0.75
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys (2000) 7.50
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med (1990) 3.69
A katanin-like protein regulates normal cell wall biosynthesis and cell elongation. Plant Cell (2001) 2.63
Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys (1995) 2.50
Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys (1995) 2.35
New manzamine alkaloids with potent activity against infectious diseases. J Am Chem Soc (2001) 2.35
Anterior transcranial (craniofacial) resection of tumors of the paranasal sinuses: surgical technique and results. Neurosurgery (1996) 2.30
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst (1996) 2.19
Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck (1997) 2.16
The influence of fibrin formation on the transplantability of murine tumour cells: implications for the mechanism of the Révész effect. Br J Cancer (1974) 2.12
Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2001) 2.11
Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med (1993) 2.10
Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys (1990) 2.07
Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys (1982) 2.05
Radiation therapy following resection of non-small cell bronchogenic carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.93
A physical concept of soil-water equilibria for nonionic organic compounds. Science (1979) 1.88
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys (1993) 1.85
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst (1992) 1.81
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys (1997) 1.70
Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys (1995) 1.70
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
The determination of hexoses and pentoses by anion-exchange chromatography: a method of high sensitivity. Anal Biochem (1976) 1.65
Is it time for a new formalism to categorize normal tissue radiation injury? Int J Radiat Oncol Biol Phys (2001) 1.58
Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys. Radiother Oncol (1995) 1.58
What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 1.55
Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.53
Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50
Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res (1999) 1.48
Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. J Natl Cancer Inst (1979) 1.48
Quality assurance in a Radiation Oncology Unit: the Chart Round experience. Australas Radiol (2001) 1.45
Metastatic thyroid cancer as an incidental finding during neck dissection: significance and management. Head Neck (1993) 1.44
Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial. Cancer J Sci Am (1999) 1.44
Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys (1995) 1.44
Peripheral nerve regeneration: the effects of postoperative irradiation. Plast Reconstr Surg (1997) 1.42
Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope (1995) 1.42
Essential role of caffeoyl coenzyme A O-methyltransferase in lignin biosynthesis in woody poplar plants. Plant Physiol (2000) 1.41
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys (1995) 1.40
The vermilion-sharing graft for repairing a vermilionectomy defect. Plast Reconstr Surg (1996) 1.39
Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations. Int J Radiat Oncol Biol Phys (1995) 1.37
Positron emission tomography (PET): experience with a large-field-of-view three-dimensional PET scanner. Med J Aust (1999) 1.36
Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer (1994) 1.35
Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys (1997) 1.33
Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer (1995) 1.31
Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.28
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
Basaloid squamous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer (1990) 1.28
Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys (1990) 1.27
Microbial delignification with white rot fungi improves forage digestibility. Appl Environ Microbiol (1993) 1.26
Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg (2001) 1.26
Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys (1983) 1.25
Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg (1995) 1.24
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol (1995) 1.24
A new isoeffect curve for change in dose per fraction. Radiother Oncol (1983) 1.23
Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol (1988) 1.23
Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg (1991) 1.19
Tissue tolerance to reirradiation. Semin Radiat Oncol (2000) 1.17
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol (1997) 1.17
Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.) Int J Radiat Oncol Biol Phys (2000) 1.16
Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. Am J Pathol (1986) 1.16
Evidence for diet effects on the composition of silk proteins produced by spiders. Mol Biol Evol (2000) 1.16
Image-guided fine-needle aspiration of the head and neck: five years' experience. Arch Otolaryngol Head Neck Surg (1998) 1.15
Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys (2000) 1.14
Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon. Br J Cancer (1975) 1.13
Juvenile nasopharyngeal angiofibroma: an update of therapeutic management. Head Neck (1996) 1.12
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol (1998) 1.11
Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res (1999) 1.11
Patterns of recurrence in malignant mixed müllerian tumor of the uterus. Cancer (1986) 1.10
Transcranial resection of tumors of the paranasal sinuses and nasal cavity. J Neurosurg (1989) 1.10
Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys (1990) 1.10
Conditioning of tissues for metastasis formation by radiation and cytotoxic drugs. Symp Fundam Cancer Res (1983) 1.10
Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck (1998) 1.10
Inhibition of artificial lung metastases in mice by pre-irradiation of abdomen. Br J Cancer (1980) 1.09
A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour. Br J Cancer (1975) 1.09
Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B. Laryngoscope (1987) 1.09
Selection costs of amino acid substitutions in ColE1 and ColIa gene clusters harbored by Escherichia coli. Mol Biol Evol (1998) 1.08